Quantcast

Latest FDA Stories

2014-07-03 23:09:54

On June 26, the FDA informed that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. (PRWEB) July 03, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Lidocaine Viscous. The FDA issued a safety...

2014-07-03 23:02:45

Zoll, Kranz & Borgess, LLC currently represents clients with injuries allegedly caused by testosterone therapy. Toledo, OH (PRWEB) July 03, 2014 The FDA is now requiring all testosterone replacement therapy products to have the general warning that these drugs may cause blood clots in the veins (Venous Thromboembolism (VTE)). Currently, the VTE warning is directly linked to polycythemia, which is when there is an increase in the number of red blood cells. Announced by the FDA June...

2014-07-02 23:09:29

On June 25, the FDA warned that specific over-the-counter topical acne products can cause rare but serious, potentially life-threatening, allergic reactions. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 02, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on over-the-counter topical acne products....

2014-07-01 23:12:54

On June 24, the FDA communicated that there is no clear evidence of increased cardiovascular risks associated with use of Olmesartan in diabetic patients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 01, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Olmesartan. The FDA issued...

2014-07-01 23:08:35

The recent FDA warning related to Lidocaine is just the latest where labeling has caused some confusion at pharmacies nationwide. The agency warned parents last week that certain oral anesthetics are not safe for teething infants and Ace Innovation Group's app OTCplus is aimed at reducing confusion about OTC medicines. Rock Hill, SC (PRWEB) July 01, 2014 The recent FDA warning related to Lidocaine is just the latest where labeling has caused some confusion at pharmacies nationwide....

2014-07-01 12:28:14

For Men Confused in the Bedroom, Dr. Emily Morse Has 5 Tips for Hitting the Big O LOS ANGELES, July 1, 2014 /PRNewswire/ -- Promescent, maker of the first FDA-compliant treatment for premature ejaculation (PE), has found that over 30% of men are not sure how to please their partner in the bedroom. The company issued surveys to men and women, and the findings are crystal clear: men need some help. According to the survey, 40% of women achieve orgasm less than half of the times they have sex,...

2014-07-01 12:27:55

AUSTIN, Texas, July 1, 2014 /PRNewswire/ -- Inova Labs Inc. ("Inova Labs"), a leading manufacturer of innovative oxygen therapy solutions has received FDA-clearance for Activox DUO2(TM), the first fully-integrated stationary and portable oxygen concentrator system. Activox DUO2(TM) combines the benefits of a home-use stationary concentrator with the portability of a best-in-class LifeChoice Activox POC into one integrated system. This unique combination provides active oxygen therapy...

2014-07-01 08:29:55

Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer THOUSAND OAKS, Calif., July 1, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to investigational bispecific T cell engager (BiTE(®)) antibody blinatumomab, for adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL), a rapidly...

2014-06-30 23:19:55

On June 24, the FDA announced that 7,379 bottles (lot 3121005) of Red Yeast Rice dietary supplement, by Doctor's Best, are recalled because they were found to contain undeclared Lovastatin. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 30, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-06-30 23:19:36

The FDA's enforcement plan makes it clear: Developing a successful CAPA program has never been more important. FDAnews and Immel Resources are offering an advanced version of their previous CAPA investigations class, fully updated to meet tough FDA scrutiny in 2014. Falls Church, VA (PRWEB) June 30, 2014 Conducting Advanced Root Cause Analysis CAPA Investigations Understanding Advanced Critical Thinking Skills and Innovative Techniques to Improve the Quality of Investigations...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related